Award details

Analysis of the folding of proteolipid protein (PLP) at the endoplasmic reticulum; links to dysmyelination diseases

ReferenceC12935
Principal Investigator / Supervisor Professor Philip Woodman
Co-Investigators /
Co-Supervisors
Professor Stephen High, Dr Eileithyia Swanton
Institution The University of Manchester
DepartmentLife Sciences
Funding typeResearch
Value (£) 196,140
StatusCompleted
TypeResearch Grant
Start date 07/08/2000
End date 06/01/2004
Duration41 months

Abstract

Proteolipid protein (PLP) is a non-glycosylated, polytopic membrane protein which is the major molecular component of myelin. Mutations within the PLP gene that prevent the gene product from folding properly at the ER give rise to severe neurodegenerative diseases, such as Pelizaeus-Merzbacher (PMD) and X-linked spastic paraplegia (SPG-2). Specifically, misfolding of PLP may be the primary cause of the widespread oligodendrocyte apoptosis that is associated with PMD. The primary aim of this project is to identify the molecular components that assist in the folding of PLP at the ER and to understand how misfolded PLP is processed by the ER quality control machinery. Based on these studies, we also intend to investigate how misfolding of PLP leads to activation of an apoptotic signalling pathway.

Summary

unavailable
Committee Closed Committee - Biochemistry & Cell Biology (BCB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file